Sublingual fentanyl citrate for control of breakthrough pain in patients referred for palliative radiotherapy

Current Oncology

Volumn 11, Issue 1, 2004, Pages 3-7

  Danjoux, Cyril ^a,b   Franssen, E ^b   Chow, E ^b   Wong, R ^b   Connolly, R ^b   Andersson, L ^a   Holden, L ^b   Stefaniuk, K ^a   Schueller, T ^a   Librach, L ^c   Pope, J ^a   Szumacher, E ^b   Hayter, C ^b  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL CITRATE;

ADULT; AGED; ANALGESIA; ARTICLE; BREAST CANCER; CANCER; CANCER PAIN; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; COLON CANCER; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG INDICATION; FEMALE; HUMAN; LUNG CANCER; MALE; MYELOMA; PALLIATIVE THERAPY; PATIENT SATISFACTION; PHASE 2 CLINICAL TRIAL; PROSTATE CANCER; SCORING SYSTEM;

EID: 2442483656     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Simmonds MA. Oral transmucosal fentanyl citrate produces pain relief faster than medication typically used for breakthrough pain in cancer patients [abstract]. Proc Am Soc Clin Oncol 1997;16:A180.
2. Stanley TH, Hague B, Mock DL, et al. Oral transmucosal fentanyl citrate (lollipop) premedication in human volunteers. Anesth Analg 1989;69:21-7.
3. Streisand JB, Varvel JR, Stanski DR, et al. Absorption and bioavailability of oral transmucosal fentanyl citrate. Anesthesiology 1991;75:223-9.
4. Lichtor JL, Sevarino FB, Joshi GP, Busch MA, Nordbrock E, Ginsberg B. The relative potency of oral transmucosal fentanyl citrate compared with intravenous morphine in the treatment of moderate to severe postoperative pain. Anesth Analg 1999;89:732-8.
5. Chandler S. Oral transmucosal fentanyl citrate: a new treatment for breakthrough pain. Am J Hosp Palliat Care 1999; 16:489-91.
6. Epstein RH, Mendel HG, Witkowski TA, et al. The safety and efficacy of oral transmucosal fentanyl citrate for preoperative sedation in young children. Anesth Analg 1996;83:1200-5.
7. Feld LH, Champeau MW, van Steennis CA, Scott JC. Preanesthetic medication in children: a comparison of oral transmucosal fentanyl citrate versus placebo. Anesthesiology 1989;75:223-9.
8. Schechter NL, Weisman SJ, Rosenblum M, Bernstein B, Conard PL. The use of oral transmucosal fentanyl citrate for painful procedures in children. Pediatrics 1995;95:335-9.
9. Sharar SR, Bratton SL, Carrougher GJ, et al. A comparison of oral transmucosal fentanyl citrate and oral hydromorphone for inpatient pediatric burn wound care analgesia. J Burn Care Rehabil 1998;19:516-21.
10. Streisand JB, Stanley TH, Hague B, van Vreeswijk H, Ho GH, Pace NL. Oral transmucosal fentanyl citrate premedication in children. Anesth Analg 1989;69:28-34.
11. Fine PG, Marcus M, De Boer AJ, Van der Oord B. An open label study of oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough cancer pain. Pain 1991;45: 149-53.
12. Danjoux C, Szumacher E, Andersson L, et al. Palliative radiotherapy at Toronto-Sunnybrook Regional Cancer Centre: the Rapid Response Radiotherapy Program. Curr Oncol 2000; 7:52-6.
13. Portenoy RK, Payne R, Coluzzi P, et al. Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study. Pain 1999; 79:303-12.
14. Hug Jr CC. Pharmakinetics of new synthetic narcotic analgesics. In: Estafanous FG, ed. Opioids in anesthesia. Boston: Butterworth; 1984:50-60.
15. Christie JM, Simmonds M, Patt R, et al. Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain. J Clin Oncol 1998; 16:3238-45.
16. Farrar JT, Cleary J, Rauck R, Busch M, Nordbrock E. Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients. J Natl Cancer Inst 1998;90:611-16.
17. Coluzzi PH, Schwartzberg L, Conroy JD, et al. Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release. Pain 2001;91:123-30.
18. Harlos M. Palliative.info [web site]. Incident pain and incident dyspnea protocol. December 8, 2002. [Available at: palliative.info/IncidentPain.htm; cited March 5, 2004]